We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,160 results
  1. Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer

    Background

    Early-stage lung cancer, primarily treated with surgery, often occur in poor surgical candidates (impaired respiratory function, prior...

    Jonathan Benzaquen, Pierre-Yves Bondiau, ... Jérôme Doyen in Radiation Oncology
    Article Open access 07 June 2023
  2. Analysis of risk characteristics for metachronous metastasis in different period of nasopharyngeal carcinoma

    Objective

    To identify the main risk factors for metachronous metastatic nasopharyngeal carcinoma (NPC) in different periods after radiotherapy and...

    Zhaodong Fei, Huiling Hong, ... Chuanben Chen in BMC Cancer
    Article Open access 17 February 2023
  3. Prognostic potential of whole exome sequencing in the clinical management of metachronous colorectal cancer liver metastases

    Background

    Colorectal cancer is a highly prevalent and deadly. The most common metastatic site is the liver. We performed a whole exome sequencing...

    Lucie Heczko, Viktor Hlaváč, ... Pavel Souček in Cancer Cell International
    Article Open access 26 November 2023
  4. Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study

    Background

    The situation of patients develo** multiple primary cancers is becoming more frequent and graver. This study investigated the risks of...

    Pariyada Tanjak, Bhoom Suktitipat, ... Vitoon Chinswangwatanakul in BMC Cancer
    Article Open access 23 September 2021
  5. Secondary Prevention of Gastrointestinal Tumors

    Gastrointestinal cancers represent a challenge for public health, especially due to their elevated incidence and poor prognosis. They have a...
    Valentina Angerilli, Matteo Fassan in Handbook of Cancer and Immunology
    Living reference work entry 2023
  6. Elucidating the clonal relationship of esophageal second primary tumors in patients with laryngeal squamous cell carcinoma

    Laryngeal cancer ranks as the second most prevalent upper airway malignancy, following Lung cancer. Although some progress has been made in managing...

    Meixuan Wan, **nxin Yang, ... Hongxue Meng in Infectious Agents and Cancer
    Article Open access 28 November 2023
  7. Stereotactic ablative body radiotherapy with a central high dose using CyberKnife for metastatic lung tumors

    Background

    The CyberKnife system features a robotically-positioned linear accelerator to deliver real-time image-guided stereotactic ablative body...

    Kazuhiko Hayashi, Osamu Suzuki, ... Kazuhiko Ogawa in BMC Cancer
    Article Open access 07 March 2023
  8. Other Less Prevalent Tumors of the Central Nervous System

    The presented tumors in this chapter are somewhat very rare, and their management is still debated due to the scarcity of information about their...
    Chapter 2023
  9. Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologies

    The widespread use of tumor DNA mismatch repair (MMR) protein immunohistochemistry in gastrointestinal tract (GIT) carcinomas has unveiled cases...

    Monika Vyas, Canan Firat, ... **ru Shia in Familial Cancer
    Article 09 October 2020
  10. Multifocal organoids reveal clonal associations between synchronous intestinal tumors with pervasive heterogeneous drug responses

    Multifocal colorectal cancer (CRC) comprises both clonally independent primary tumors caused by inherited predisposition and clonally related tumors...

    Nahyun Jeong, Soon-Chan Kim, ... Ja-Lok Ku in npj Genomic Medicine
    Article Open access 19 July 2022
  11. Evaluation of functional outcome of bilateral kidney tumors after sequential surgery

    Background

    There are limited data concerning patients treated with sequential bilateral kidney surgery. Current guidelines still lack an optimal...

    Jung Kwon Kim, Hwanik Kim, ... Seok-Soo Byun in BMC Cancer
    Article Open access 24 May 2021
  12. Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer

    Background

    NSCLC patients with EGFR mutation were at a higher incidence of develo** brain metastasis (BM). Patients with BM are associated with high...

    Wen Ouyang, **g Yu, ... Conghua **e in BMC Cancer
    Article Open access 30 July 2020
  13. Emerging trends in the coexistence of primary lung Cancer and hematologic malignancy: a comprehensive analysis of clinicopathological features and genetic abnormalities

    Background

    The incidence of multiple primary cancers (MPC), especially involving primary lung cancer (PLC) and primary hematologic malignancies (PHM),...

    Mengchen Lyu, Lifeng Luo, ... Yi **ang in Cancer Cell International
    Article Open access 24 February 2024
  14. Reconstructing Phylogenetic Relationship in Bladder Cancer: A Methodological Overview

    Bladder cancer (BC) expresses itself as a highly heterogeneous disease both at the histological and molecular level, often occurring as synchronous...
    Lancelot Seillier, Martin Peifer in Urothelial Carcinoma
    Protocol 2023
  15. Gene expression profiling for the diagnosis of multiple primary malignant tumors

    Background

    The incidence of multiple primary malignant tumors (MPMTs) is rising due to the development of screening technologies, significant...

    Yu Zheng, Yifeng Sun, ... Hongming Pan in Cancer Cell International
    Article Open access 12 January 2021
  16. The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice

    Background

    Breast cancer (BC) and differentiated thyroid cancer (TC) are two common cancer types with the highest incidence in women. BC and TC can...

    Marceline W. Piek, Jan Paul de Boer, ... Iris M. C. van der Ploeg in BMC Cancer
    Article Open access 26 September 2022
  17. A case of Ph+ acute lymphoblastic leukemia and EGFR mutant lung adenocarcinoma synchronous overlap: may one TKI drug solve two diseases?

    Background

    Philadelphia chromosome positive (Ph + ) acute lymphoblastic leukemia (ALL) refers to ALL patients with t(9;22) cytogenetic abnormalities,...

    Qi Zhang, **g-dong Zhou, ... Ting-juan Zhang in BMC Medical Genomics
    Article Open access 08 July 2024
  18. The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma

    Background

    The aim of the present study was to assess the prevalence of deficient mismatch repair (MMR) in Chinese ovarian clear cell carcinoma (CCC)...

    Shuang Ye, Shuling Zhou, ... Huijuan Yang in BMC Cancer
    Article Open access 23 April 2022
  19. Clinicomics-guided distant metastasis prediction in breast cancer via artificial intelligence

    Background

    Breast cancer has become the most common malignant tumour worldwide. Distant metastasis is one of the leading causes of breast...

    Chao Zhang, Lisha Qi, ... Wenjuan Ma in BMC Cancer
    Article Open access 14 March 2023
  20. Impact of Driver Mutations on the Evolution of Isolated Metachronous Lung Metastasis of Pancreatic Ductal adenocarcinoma

    Background

    The incidence of pancreatic ductal adenocarcinoma (PDAC) is increasing sharply. The survival of patients with metastases is usually about a...

    Carole Vitellius, Océane Griveaux, ... François-Xavier Caroli-Bosc in Molecular Diagnosis & Therapy
    Article 10 June 2020
Did you find what you were looking for? Share feedback.